Evidence map›Paper›PMID 30429232›Full record

ArticleBioscience reports2019

Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines

Tao Zhang, Wei Chen, Xumian Jiang, Lei Liu, Kai Wei, Hansong Du, Hui Wang, Juan Li

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05802992 phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

A Single-center Clinical Trial to Evaluate the Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients

TypeinterventionalSponsorAffiliated Hospital of Nantong UniversityRan2022 to 2024Enrolled30ConditionsMultiple MyelomaArmsColchicine, Lenalidomide
NCT06304896 phase1unknown statusnot on this mapstarted 2024, after this paper: background citation

Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy

TypeinterventionalSponsorArab Contractors Medical CentreRan2024 to 2025Enrolled150ConditionsChemotherapy Induced Systolic DysfunctionArmsCarvedilol, Ramipril, Rosuvastatin, Colchicine, Placebo
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Colchicine ofCell journal · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tao ZhangDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China lijuan@linuxmail.org taozhang@graduate.org.
Wei ChenDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China.
Xumian JiangDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China.
Lei LiuDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China.
Kai WeiDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China.
Hansong DuDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China.
Hui WangDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China.
Juan LiDepartment of Gastrointestinal Surgery, The Center Hospital of Wuhan, TongJi Medical College, HuaZhong University of Science and Techonolgoy, Wuhan 430060, China lijuan@linuxmail.org taozhang@graduate.org.ORCID 0000-0003-0033-3887
Huazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study investigated the effects of Colchicine on gastric carcinoma (GC) cells and explored its possible mechanisms underlying such effects. The results of MTT and colony formation assays showed that Colchicine (2, 5, and 10 ng/ml) markedly inhibited the proliferation of AGS and NCI-N87 cells in a dose-dependent manner. It also led to a reduction in cell migration in both GC cells as determined by Transwell migration assay. Mover, data form Hoechst 33342 staining and flow cytometry assay indicated that Colchicine (2, 5, and 10 ng/ml) promoted the apoptosis of NCI-N87 cells. In addition, the release of cytochrome

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAntineoplastic Agents, PhytogenicApoptosisbcl-2-Associated X ProteinCaspase 3Cell Line, TumorCell MovementCell ProliferationColchicineCytochromes cDose-Response Relationship, DrugEpithelial CellsHumansMaleMiceAntineoplastic Agents, PhytogenicBax protein, mousebcl-2-Associated X ProteinBcl2 protein, mouseCasp3 protein, mouseCaspase 3ColchicineCytochromes cProto-Oncogene Proteins c-bcl-2apoptosiscaspase-3Colchicinegastric cancermitochondrial apoptotic pathways

Identifiers

PMID30429232
PMCPMC6331673
OpenAlexW2901096402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.